Correlation Between HAVN Life and Algernon Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HAVN Life and Algernon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HAVN Life and Algernon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HAVN Life Sciences and Algernon Pharmaceuticals, you can compare the effects of market volatilities on HAVN Life and Algernon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HAVN Life with a short position of Algernon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of HAVN Life and Algernon Pharmaceuticals.

Diversification Opportunities for HAVN Life and Algernon Pharmaceuticals

-0.35
  Correlation Coefficient

Very good diversification

The 3 months correlation between HAVN and Algernon is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding HAVN Life Sciences and Algernon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algernon Pharmaceuticals and HAVN Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HAVN Life Sciences are associated (or correlated) with Algernon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algernon Pharmaceuticals has no effect on the direction of HAVN Life i.e., HAVN Life and Algernon Pharmaceuticals go up and down completely randomly.

Pair Corralation between HAVN Life and Algernon Pharmaceuticals

Assuming the 90 days horizon HAVN Life Sciences is expected to generate 20.24 times more return on investment than Algernon Pharmaceuticals. However, HAVN Life is 20.24 times more volatile than Algernon Pharmaceuticals. It trades about 0.21 of its potential returns per unit of risk. Algernon Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest  0.01  in HAVN Life Sciences on August 31, 2024 and sell it today you would earn a total of  0.51  from holding HAVN Life Sciences or generate 5100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HAVN Life Sciences  vs.  Algernon Pharmaceuticals

 Performance 
       Timeline  
HAVN Life Sciences 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in HAVN Life Sciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly conflicting essential indicators, HAVN Life reported solid returns over the last few months and may actually be approaching a breakup point.
Algernon Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Algernon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Algernon Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

HAVN Life and Algernon Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HAVN Life and Algernon Pharmaceuticals

The main advantage of trading using opposite HAVN Life and Algernon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HAVN Life position performs unexpectedly, Algernon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algernon Pharmaceuticals will offset losses from the drop in Algernon Pharmaceuticals' long position.
The idea behind HAVN Life Sciences and Algernon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Bonds Directory
Find actively traded corporate debentures issued by US companies
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets